PROGYNOVA

Main information

  • Trade name:
  • PROGYNOVA 1 mg coated tablet
  • Dosage:
  • 1 mg
  • Pharmaceutical form:
  • coated tablet
  • Prescription type:
  • Prescription only
  • Medicine domain:
  • Humans
  • Medicine type:
  • Allopathic drug

Documents

Localization

  • Available in:
  • PROGYNOVA 1 mg coated tablet
    Finland
  • Language:
  • English

Therapeutic information

  • Therapeutic area:
  • Estradiol
  • Product summary:
  • Suitability for use in older adult patients Estradioli valeras Suitable as a topical treatment in older women (category A). Avoid systemic use in older persons (category D). Contraindication: oestrogen-dependent cancer. In systemic use, take adverse effects into account, such as risk of cardiovascular diseases and venous thromboembolisms. Take interactions into account.

Status

  • Source:
  • Fimea
  • Authorization status:
  • Marketing authorization granted
  • Authorization number:
  • 5836
  • Authorization date:
  • 29-01-2009
  • Last update:
  • 26-07-2018